Find out what happened in the markets today - and why you should care - with the free Daily Brief newsletter.

Positive US inflation data is setting the stage for a rebound in Indian equity markets on Monday, despite challenges from the Federal Reserve's tighter monetary policy.

What does this mean?

US inflation figures showed just a 0.1% rise in November's PCE price index, boosting confidence across Asian markets, with the MSCI Asia ex-Japan index up 1.1%. This positivity is likely to extend to Indian equities, as suggested by optimistic GIFT Nifty futures. Still, the Fed's choice to reduce its expected rate cuts for 2025 from four to two over inflation worries might temper this buoyancy. This change has triggered significant foreign outflows from Indian stocks, with the Nifty 50 dropping 4.8% last week -- the biggest decline since mid-2022. The $1.86 billion in foreign outflows last week highlights the fine line that Indian markets must tread between global and local economic influences.

Regional optimism might lift Indian stocks initially, but caution is essential as foreign investors recalibrate their strategies in response to evolving US monetary policies. On Friday, foreign institutional investors withdrew 35.98 billion rupees from Indian equities, which pressures other emerging markets and calls for prudent optimism.

The bigger picture: Tides of change across the spectrum.

Amid market fluctuations, sectors like cement and pharmaceuticals are making strategic moves, with Ultratech Cement and Aurobindo Pharma advancing in regulatory arenas. Meanwhile, the steel sector is under review with import investigations. These events highlight industry shifts impacting the broader economic and investment landscape in India.